SEC Form 4 · accession 0001615774-18-005327
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory M Sullivan
Officer — Chief Medical Officer
Period of report
Jun 14, 2018
Accepted (ET)
Jun 15, 2018 · 7:05 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Jun 14, 2018 | P | 10,000 | $3.965 | A | 20,482 | D |
Table II — derivative securities
No Table II lines on this filing.